Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study
Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls. There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion...
Saved in:
Published in | Investigative ophthalmology & visual science Vol. 53; no. 7; p. 3913 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
25.06.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1552-5783 1552-5783 |
DOI | 10.1167/iovs.11-8453 |
Cover
Loading…
Abstract | Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.
There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.
A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.
The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia. |
---|---|
AbstractList | Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.
There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.
A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.
The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia. Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.PURPOSEOur prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.METHODSThere were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.RESULTSA total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia.CONCLUSIONSThe current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia. |
Author | Hiraoka, Takahiro Kakita, Tetsuhiko Takahashi, Hideto Oshika, Tetsuro Okamoto, Fumiki |
Author_xml | – sequence: 1 givenname: Takahiro surname: Hiraoka fullname: Hiraoka, Takahiro organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan – sequence: 2 givenname: Tetsuhiko surname: Kakita fullname: Kakita, Tetsuhiko organization: Kakita Eye Clinic, Chiba, Japan; and – sequence: 3 givenname: Fumiki surname: Okamoto fullname: Okamoto, Fumiki organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan – sequence: 4 givenname: Hideto surname: Takahashi fullname: Takahashi, Hideto organization: Epidemiology and Biostatistics, School of Medicine, University of Tsukuba, Ibaraki, Japan – sequence: 5 givenname: Tetsuro surname: Oshika fullname: Oshika, Tetsuro organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22577080$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1PGzEUxK0qVQm0t56RjxzY4o843u0tigJUCsoBcuhp5fU-Zw3OOthOaP77OoSiqurpjUa_eYeZUzTofQ8IfaXkG6VjeWX9LmZVlCPBP6AhFYIVQpZ88Jc-QacxPhLCKGXkEzphTEhJSjJEu7nvV8UDhDWeGQM6YW_wYgeht6su4UVInX-CoJJ3frXHvseTX1Y5PId-lTo8czmuks2-7fG0s67tvG_x3d5vrPqOJ1gUP0EFfO2d8y_FcoPv07bdf0YfjXIRvrzdM7S8nj1Mb4v54ubHdDIvNBcyFZoyro2ojCSt0XI0bsdgSEUq3kjeiLJpsktlxfiogha4ZkLTRlZ0pCjISvAzdHH8uwn-eQsx1WsbNTinevDbWFPCchclGcuMnr-h22YNbb0Jdq3Cvv7TVQYuj4AOPsYA5h2hpD5MUR-myKo-TJFx9g-ubXqtKgVl3f9DvwF1TI0H |
CitedBy_id | crossref_primary_10_1186_s40662_025_00427_3 crossref_primary_10_1007_s00417_023_06301_z crossref_primary_10_1111_cxo_12666 crossref_primary_10_3389_fmed_2023_1207328 crossref_primary_10_1111_opo_12834 crossref_primary_10_1016_j_clae_2020_07_001 crossref_primary_10_1016_j_ophtha_2015_11_010 crossref_primary_10_1007_s10792_020_01658_0 crossref_primary_10_1111_opo_13365 crossref_primary_10_1016_j_ajo_2013_04_039 crossref_primary_10_12968_opti_2016_12_148872 crossref_primary_10_1097_ICL_0000000000000476 crossref_primary_10_1097_OPX_0000000000000573 crossref_primary_10_1155_2015_360806 crossref_primary_10_1186_s12967_024_05075_0 crossref_primary_10_1097_OPX_0000000000002197 crossref_primary_10_1007_s00347_019_0873_7 crossref_primary_10_1097_OPX_0000000000002060 crossref_primary_10_1364_JOSAA_450195 crossref_primary_10_52725_aocl_2024_23_2_51 crossref_primary_10_1016_j_clae_2024_102342 crossref_primary_10_1007_s00417_016_3554_0 crossref_primary_10_1016_j_clae_2019_12_001 crossref_primary_10_1111_opo_12027 crossref_primary_10_1016_j_clae_2023_102088 crossref_primary_10_1111_opo_13354 crossref_primary_10_1016_j_clae_2015_07_002 crossref_primary_10_1016_j_clae_2018_10_026 crossref_primary_10_1016_j_clae_2023_102094 crossref_primary_10_1097_ICL_0000000000000460 crossref_primary_10_1097_ICU_0000000000000367 crossref_primary_10_1097_ICL_0000000000000222 crossref_primary_10_1186_s12886_016_0302_5 crossref_primary_10_1186_s40662_020_00214_2 crossref_primary_10_1097_ICL_0000000000000100 crossref_primary_10_1159_000516907 crossref_primary_10_1016_j_clae_2016_02_003 crossref_primary_10_1186_s40662_025_00426_4 crossref_primary_10_1097_ICL_0000000000000207 crossref_primary_10_1016_j_clae_2022_101723 crossref_primary_10_1007_s10384_018_0616_3 crossref_primary_10_3390_children10020402 crossref_primary_10_1186_s12886_022_02635_0 crossref_primary_10_21516_2072_0076_2022_15_1_46_50 crossref_primary_10_12677_ACM_2020_104075 crossref_primary_10_3390_photonics11040332 crossref_primary_10_1167_tvst_11_2_18 crossref_primary_10_1016_j_clae_2020_11_015 crossref_primary_10_1186_s40662_023_00358_x crossref_primary_10_1097_OPX_0000000000001207 crossref_primary_10_1097_APO_0000000000000256 crossref_primary_10_1186_s12886_020_01477_y crossref_primary_10_1371_journal_pone_0111766 crossref_primary_10_1097_ICL_0000000000000699 crossref_primary_10_3390_jcm10020336 crossref_primary_10_4103_pajo_pajo_119_21 crossref_primary_10_1111_aos_15746 crossref_primary_10_1111_opo_13213 crossref_primary_10_1186_s13063_021_05197_6 crossref_primary_10_1016_j_ophtha_2014_09_028 crossref_primary_10_1186_s13063_023_07799_8 crossref_primary_10_1111_aos_14658 crossref_primary_10_3389_fmed_2022_1069649 crossref_primary_10_1111_cxo_13067 crossref_primary_10_1016_j_clae_2019_03_003 crossref_primary_10_1007_s10384_023_01012_8 crossref_primary_10_1016_j_optom_2022_03_002 crossref_primary_10_1016_j_clae_2018_10_006 crossref_primary_10_3390_jpm12081316 crossref_primary_10_1080_02713683_2023_2167212 crossref_primary_10_15406_aovs_2016_05_00154 crossref_primary_10_1080_08164622_2021_1896944 crossref_primary_10_1016_j_heliyon_2024_e33341 crossref_primary_10_3390_jcm10040730 crossref_primary_10_1097_APO_0000000000000242 crossref_primary_10_17116_oftalma2017133149_54 crossref_primary_10_1007_s00717_019_0431_3 crossref_primary_10_1097_ICL_0000000000000566 crossref_primary_10_1016_j_clae_2019_11_012 crossref_primary_10_1186_1471_2415_14_141 crossref_primary_10_1111_cxo_12987 crossref_primary_10_1186_s40662_024_00403_3 crossref_primary_10_1111_opo_13208 crossref_primary_10_1080_09273972_2016_1276940 crossref_primary_10_1111_cxo_12862 crossref_primary_10_1155_2017_3703854 crossref_primary_10_1097_OPX_0000000000000808 crossref_primary_10_1136_bjophthalmol_2020_317980 crossref_primary_10_3341_kjo_2016_30_6_434 crossref_primary_10_1167_iovs_62_5_6 crossref_primary_10_1097_OPX_0000000000000259 crossref_primary_10_1097_OPX_0000000000001106 crossref_primary_10_1016_j_clae_2022_101749 crossref_primary_10_1016_j_rfo_2019_10_012 crossref_primary_10_1167_iovs_18_25955 crossref_primary_10_1038_s41598_023_34580_3 crossref_primary_10_1002_14651858_CD013549_pub2 crossref_primary_10_1080_08164622_2022_2113330 crossref_primary_10_12998_wjcc_v9_i30_8985 crossref_primary_10_1097_ICL_0000000000000313 crossref_primary_10_1167_iovs_18_25958 crossref_primary_10_1097_ICL_0000000000000539 crossref_primary_10_1186_s12886_022_02310_4 crossref_primary_10_1111_opo_12460 crossref_primary_10_1016_j_clae_2024_102303 crossref_primary_10_1186_s12886_021_02123_x crossref_primary_10_1080_08164622_2021_1970480 crossref_primary_10_1186_s12886_022_02480_1 crossref_primary_10_1007_s00417_014_2865_2 crossref_primary_10_1097_OPX_0000000000000916 crossref_primary_10_1016_j_yaoo_2019_04_015 crossref_primary_10_1080_08164622_2024_2447469 crossref_primary_10_4263_jorthoptic_53F104 crossref_primary_10_1016_j_clae_2021_02_003 crossref_primary_10_1364_BOE_486555 crossref_primary_10_1016_j_clae_2020_06_006 crossref_primary_10_3109_02713683_2015_1050743 crossref_primary_10_1097_ICL_0000000000000665 crossref_primary_10_1371_journal_pone_0243416 crossref_primary_10_1097_OPX_0000000000001573 crossref_primary_10_3109_02713683_2015_1009634 crossref_primary_10_1080_15599612_2020_1857889 crossref_primary_10_2147_IJGM_S355181 crossref_primary_10_1038_s41598_023_32700_7 crossref_primary_10_1186_s12886_024_03398_6 crossref_primary_10_1080_02713683_2019_1701685 crossref_primary_10_1097_ICO_0000000000001725 crossref_primary_10_1016_j_clae_2025_102376 crossref_primary_10_1016_j_jfma_2019_02_001 crossref_primary_10_3389_fneur_2022_1006112 crossref_primary_10_1002_14651858_CD013549 crossref_primary_10_1016_j_clae_2015_07_006 crossref_primary_10_3390_antibiotics11020179 crossref_primary_10_1016_j_clae_2025_102381 crossref_primary_10_3390_jcm14030662 crossref_primary_10_1016_j_clae_2014_05_004 crossref_primary_10_1136_bjo_2023_324243 crossref_primary_10_1371_journal_pone_0175913 crossref_primary_10_3341_jkos_2020_61_8_897 crossref_primary_10_1097_OPX_0000000000001127 crossref_primary_10_1136_bjophthalmol_2018_312933 crossref_primary_10_1097_OPX_0000000000000034 crossref_primary_10_1167_tvst_7_6_17 crossref_primary_10_1097_OPX_0000000000000036 crossref_primary_10_1097_OPX_0000000000001367 crossref_primary_10_1167_iovs_18_25977 crossref_primary_10_3389_fbioe_2021_743745 crossref_primary_10_3389_fmed_2023_1130117 crossref_primary_10_1097_ICL_0000000000000516 crossref_primary_10_1080_08164622_2023_2177098 crossref_primary_10_1155_2022_5530162 crossref_primary_10_1111_cxo_12976 crossref_primary_10_12968_opti_2019_12_8057 crossref_primary_10_1016_j_clae_2022_101755 crossref_primary_10_1016_j_exer_2012_11_019 crossref_primary_10_1007_s10384_021_00873_1 crossref_primary_10_1080_08164622_2021_1943318 crossref_primary_10_1111_cxo_12297 crossref_primary_10_1111_opo_12686 crossref_primary_10_3390_vision6020020 crossref_primary_10_1111_ceo_14149 crossref_primary_10_4102_aveh_v79i1_499 crossref_primary_10_1038_s41598_020_71142_3 crossref_primary_10_1097_ICL_0000000000001054 crossref_primary_10_3341_jkos_2024_65_12_786 crossref_primary_10_1097_ICL_0000000000000520 crossref_primary_10_1186_s40662_022_00304_3 crossref_primary_10_1371_journal_pone_0203652 crossref_primary_10_2147_OPTH_S362342 crossref_primary_10_1097_ICL_0000000000000867 crossref_primary_10_1111_cxo_12947 crossref_primary_10_17337_JMBI_2024_26_3_207 crossref_primary_10_1097_ICL_0000000000000629 crossref_primary_10_3109_02713683_2013_841259 crossref_primary_10_1371_journal_pone_0282286 crossref_primary_10_1111_opo_12676 crossref_primary_10_1016_j_jfo_2022_02_003 crossref_primary_10_1186_s12886_022_02693_4 crossref_primary_10_1136_bjo_2023_323764 crossref_primary_10_1136_bjophthalmol_2020_317664 crossref_primary_10_1038_s41467_024_46049_6 crossref_primary_10_1136_bjophthalmol_2021_320318 crossref_primary_10_1155_2017_3279821 crossref_primary_10_1186_s40662_023_00339_0 crossref_primary_10_1038_s41598_020_59157_2 crossref_primary_10_1080_02713683_2020_1820528 crossref_primary_10_1016_j_clae_2017_10_014 crossref_primary_10_1097_OPX_0000000000002119 crossref_primary_10_1002_stem_1984 crossref_primary_10_1080_02713683_2016_1221979 crossref_primary_10_1159_000510779 crossref_primary_10_1371_journal_pmed_1002674 crossref_primary_10_1016_j_clae_2022_101774 crossref_primary_10_1097_ICL_0000000000000977 crossref_primary_10_1111_aos_13866 crossref_primary_10_1007_s40123_023_00755_4 crossref_primary_10_1016_j_clae_2020_05_001 crossref_primary_10_1016_j_clae_2024_102192 crossref_primary_10_1038_eye_2013_255 crossref_primary_10_3389_fped_2022_1057863 crossref_primary_10_1038_eye_2013_256 crossref_primary_10_1097_OPX_0000000000000843 crossref_primary_10_1111_opo_13070 crossref_primary_10_1016_j_clae_2017_10_006 crossref_primary_10_1016_j_clae_2015_06_009 crossref_primary_10_1111_cxo_12839 crossref_primary_10_1186_s12886_021_01865_y crossref_primary_10_21516_2072_0076_2020_13_3_56_60 crossref_primary_10_1186_s40662_024_00418_w crossref_primary_10_52725_aocl_2024_23_4_139 crossref_primary_10_1016_j_clae_2023_101841 crossref_primary_10_1155_2020_8067657 crossref_primary_10_1038_s41433_023_02723_5 crossref_primary_10_1097_ICL_0000000000000848 crossref_primary_10_1016_j_ophtha_2014_07_042 crossref_primary_10_1111_opo_12895 crossref_primary_10_1136_bjophthalmol_2020_316475 crossref_primary_10_1007_s00417_019_04555_0 crossref_primary_10_1097_ICL_0000000000000290 crossref_primary_10_1097_ICL_0000000000001142 crossref_primary_10_1007_s10792_024_03175_w crossref_primary_10_1097_ICL_0000000000000172 crossref_primary_10_12677_HJO_2016_53015 crossref_primary_10_17116_oftalma201913504160 crossref_primary_10_1016_j_biopha_2020_111092 crossref_primary_10_1097_MD_0000000000040139 crossref_primary_10_1167_iovs_17_23707 crossref_primary_10_1016_j_clae_2023_101852 crossref_primary_10_1016_j_clae_2013_09_007 crossref_primary_10_1097_OPX_0000000000000183 crossref_primary_10_1111_aos_16678 crossref_primary_10_1016_j_jfma_2021_05_024 crossref_primary_10_1007_s10384_018_0608_3 crossref_primary_10_1016_j_clae_2024_102167 crossref_primary_10_5318_wjo_v4_i3_63 crossref_primary_10_3928_01913913_20170106_01 crossref_primary_10_1016_j_ophtha_2018_11_026 crossref_primary_10_1186_s12886_022_02294_1 crossref_primary_10_1111_opo_12641 crossref_primary_10_1016_j_clae_2017_09_010 crossref_primary_10_1097_OPX_0000000000000989 crossref_primary_10_1016_j_clae_2014_11_201 crossref_primary_10_1016_j_clae_2024_102172 crossref_primary_10_1136_bmjophth_2023_001499 crossref_primary_10_17116_oftalma2017133543_48 crossref_primary_10_1093_emph_eoy017 crossref_primary_10_1371_journal_pone_0218140 crossref_primary_10_1177_11206721241260456 crossref_primary_10_1097_OPX_0000000000000064 crossref_primary_10_33791_2222_4408_2021_3_47_52 crossref_primary_10_1097_ICL_0000000000001017 crossref_primary_10_1097_OPX_0000000000000066 crossref_primary_10_1016_j_ophtha_2021_04_032 crossref_primary_10_1111_aos_15217 crossref_primary_10_1111_opo_12990 crossref_primary_10_1007_s10384_021_00842_8 crossref_primary_10_1016_j_clae_2023_101862 crossref_primary_10_3109_02713683_2013_790977 crossref_primary_10_1111_opo_13042 crossref_primary_10_1111_cxo_12584 crossref_primary_10_1038_s41598_017_08177_6 crossref_primary_10_1080_09286586_2021_1875010 crossref_primary_10_1038_s41598_019_49041_z crossref_primary_10_1186_s12886_022_02461_4 crossref_primary_10_1080_08164622_2022_2039555 crossref_primary_10_1136_bjo_2022_321272 crossref_primary_10_3389_fmed_2023_1323851 crossref_primary_10_1097_OPX_0000000000000894 crossref_primary_10_3341_jkos_2018_59_11_1009 crossref_primary_10_5124_jkma_2016_59_1_39 crossref_primary_10_1097_ICL_0000000000001006 crossref_primary_10_1186_s12886_022_02562_0 crossref_primary_10_1016_j_clae_2023_101875 crossref_primary_10_1038_s41598_020_69710_8 crossref_primary_10_1080_02713683_2021_1917619 crossref_primary_10_1111_cxo_12358 crossref_primary_10_1111_aos_14911 crossref_primary_10_1016_j_xops_2024_100563 crossref_primary_10_1038_s41598_020_71710_7 crossref_primary_10_1111_opo_12744 crossref_primary_10_1016_j_clae_2023_102047 crossref_primary_10_1111_opo_12621 crossref_primary_10_3341_jkos_2022_63_4_338 crossref_primary_10_12968_opti_2016_5_127 crossref_primary_10_1016_j_clae_2020_03_018 crossref_primary_10_1097_OPX_0000000000001977 crossref_primary_10_1016_j_heliyon_2023_e14887 crossref_primary_10_1097_OPX_0000000000000762 crossref_primary_10_1097_OPX_0000000000002028 crossref_primary_10_1016_j_clae_2021_101517 crossref_primary_10_1111_aos_16775 crossref_primary_10_1111_opo_13388 crossref_primary_10_1097_ICL_0000000000000801 crossref_primary_10_1111_opo_13029 crossref_primary_10_1016_j_preteyeres_2020_100923 crossref_primary_10_1111_opo_12614 crossref_primary_10_1007_s10792_019_01167_9 crossref_primary_10_1016_j_clae_2024_102256 crossref_primary_10_1016_j_clae_2024_102251 crossref_primary_10_1016_j_clae_2024_102131 crossref_primary_10_1016_j_clae_2020_03_002 crossref_primary_10_1097_ICL_0000000000000252 crossref_primary_10_1155_2023_5553468 crossref_primary_10_1097_ICL_0000000000000493 crossref_primary_10_1097_ICL_0000000000000371 crossref_primary_10_3341_jkos_2019_60_7_620 crossref_primary_10_1097_ICL_0000000000000014 crossref_primary_10_1097_ICL_0b013e318298ee76 crossref_primary_10_1097_OPX_0000000000001520 crossref_primary_10_3928_01913913_20181212_02 crossref_primary_10_1097_ICL_0000000000000499 crossref_primary_10_1111_cxo_12339 crossref_primary_10_1007_s10384_021_00854_4 crossref_primary_10_1186_s12886_021_02148_2 crossref_primary_10_1016_j_clae_2022_101597 crossref_primary_10_1080_02713683_2019_1673438 crossref_primary_10_17116_oftalma2017133389_98 crossref_primary_10_1186_s12886_023_03178_8 crossref_primary_10_1007_s10792_021_01855_5 crossref_primary_10_1016_j_clae_2024_102246 crossref_primary_10_1111_opo_12722 crossref_primary_10_1038_s41433_024_02987_5 crossref_primary_10_1016_j_clae_2016_12_002 crossref_primary_10_1080_07853890_2023_2282745 crossref_primary_10_1136_bmjophth_2018_000204 crossref_primary_10_1186_s12886_017_0639_4 crossref_primary_10_1016_j_clae_2020_08_011 crossref_primary_10_1186_s40662_022_00324_z crossref_primary_10_1007_s10384_020_00751_2 crossref_primary_10_1111_aos_15662 crossref_primary_10_1177_1120672121998960 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1167/iovs.11-8453 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1552-5783 |
ExternalDocumentID | 22577080 10_1167_iovs_11_8453 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- 18M 2WC 34G 39C 5GY 5RE AAYXX ACGFO ACNCT ADBBV AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION CS3 DIK DU5 E3Z EBS EJD F5P GROUPED_DOAJ GX1 N9A OK1 P2P RPM SJN TR2 TRV W8F WH7 WOQ WOW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c357t-c123cf59f70dfc746d6ef09093b73b58bbfc71792349ede3c25c1b7914a1e7953 |
ISSN | 1552-5783 |
IngestDate | Sun Aug 24 04:15:45 EDT 2025 Thu Apr 03 06:54:23 EDT 2025 Tue Jul 01 02:29:54 EDT 2025 Thu Apr 24 23:06:07 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c357t-c123cf59f70dfc746d6ef09093b73b58bbfc71792349ede3c25c1b7914a1e7953 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 22577080 |
PQID | 1022258067 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_1022258067 pubmed_primary_22577080 crossref_primary_10_1167_iovs_11_8453 crossref_citationtrail_10_1167_iovs_11_8453 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-06-25 |
PublicationDateYYYYMMDD | 2012-06-25 |
PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-25 day: 25 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Investigative ophthalmology & visual science |
PublicationTitleAlternate | Invest Ophthalmol Vis Sci |
PublicationYear | 2012 |
SSID | ssj0021120 |
Score | 2.5554008 |
Snippet | Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 3913 |
SubjectTerms | Axial Length, Eye - physiopathology Child Eyeglasses Female Follow-Up Studies Humans Male Myopia - physiopathology Myopia - therapy Orthokeratologic Procedures Prospective Studies Time Factors |
Title | Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22577080 https://www.proquest.com/docview/1022258067 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDflJSPBqcrSrJM44YZgqwX2cUml3iLHsUlIG1dtUlh-Bz-YcZy4XdiVFi6R5Thu5fkymbFnvkHoteelJCAu-CaZSDWpNnMYzeB155yQVEgZCZ0ofHIaHE29zzN_Nhj82olaaup0n_-8NK_kf6QKfSBXnSX7D5K1k0IHtEG-cAUJw_VaMj5W1VdH69YuLENbfm3tXO1xj_SJjCo1abLhWdJxxz_0BrkunlLnIzGHx1kf7Mgtx_HiXC0LZrKgfedcM_1IQIv67jTLHTrab30MvCXq2IiRWuZ1zuYL84saVpti3fSJlzsoKlZMla3hGrOS5cVKWdUPNq0xaWNRr5u8KO2ts5IBstrN3UmzKMpiu-9Q6tS03JTgLjJRq93tDB0XEjgm9bnXwD54x9RUt9kXl_R1attwDHfwpDs6mEQmu_Xvj0Ogj6cLtVlD2wm9boYLHNynZ8lkenycxIez-Aa6eQDOh66L8fHTF-vGu4bs0_6pPp0ioG93575o6FzhvbRWTHwX3encD_zeYOkeGojqPrp10gVYPEAbCylsIIWVxBZS-A9IYVXhFlLYQApvIYWLCltIYQOpd5hhAyhsAYVbQD1E08lh_OHI6UpzOJz4tHY4GDxc-pGk40xy6gVZIOQ4GkckpST1wzSFXldzU3qRyAThBz53Uxq5HnMFjXzyCO1VqhJPEA6FJFlGCMxFPBZ4LEwl41mYESk9lkVDNOrXMeEdb70unzJPWv81oIledWgletWH6I0dvTR8LVeMe9WLJAGFqk_JWCVUAwPaLZAQrLghemxkZWeCG5SCj_X0Gk8_Q7e3-H6O9upVI16AAVunL1s8_QYa06Uo |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+effect+of+overnight+orthokeratology+on+axial+length+elongation+in+childhood+myopia%3A+a+5-year+follow-up+study&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Hiraoka%2C+Takahiro&rft.au=Kakita%2C+Tetsuhiko&rft.au=Okamoto%2C+Fumiki&rft.au=Takahashi%2C+Hideto&rft.date=2012-06-25&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=53&rft.issue=7&rft.spage=3913&rft_id=info:doi/10.1167%2Fiovs.11-8453&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon |